Stepan Company (96S) AI Stock Analysis
Stepan Company
(Frankfurt:96S)
No summary available
Stepan Company (96S) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 1.60B
- Dividend Yield
- 2.22%
- Average Volume (3M)
- 300
- Price to Earnings (P/E)
- 370.0
- Beta (1Y)
- 0.75
- Revenue Growth
- 4.62%
- EPS Growth
- -90.10%
- Country
- Germany
- Employees
- 2,328
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals - Specialty
Stepan Company Business Overview & Revenue Model
Company Description
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and international...
Stepan Company Earnings Call Summary
The call was strongly positive overall. Highlights significantly outweighed the challenges, with broad-based volume and earnings growth, higher margins, savings ahead of plan, improved leverage, positive free cash flow, customer expansion, and a positive full-year outlook. The main negatives were raw material and geopolitical volatility, working capital usage, restructuring and maintenance costs, weaker European and Asian demand, lower crop productivity demand, and expected moderation in fourth-quarter volume growth.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
For 2026, Stepan expects to exceed the 60% 2-year $100 million pretax savings target, with Project Catalyst savings in the $66 million to $70 million range, versus a $23 million run rate in Q3; for 2027, it expects to be ahead of $25 million on average, with savings ahead of $25 million in the second half and slightly below $25 million in the first half. The company expects lower growth in Q4, and its fixed cost base is roughly $800 million, with normal inflation of 2%-3% on that base. Pasadena utilization is in the 75%-80% range, with more tolling savings expected in the second half than the first half of next year. For 2026, the company expects full year adjusted EBITDA growth, positive free cash flow, and continued deleveraging of the balance sheet.
Stepan Company Risk Analysis
Stepan Company disclosed 21 risk factors in its most recent earnings report. Stepan Company reported the most risks in the "Production" category.
Latest Risks Added
0 New RisksStepan Company Peers Comparison
Overall Rating
IOSP69Neutral
FUL68Neutral
ESI62Neutral
KWR60Neutral
ASH56Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 69Neutral | $2.46B | 20.27 | 9.15% | 1.80% | 2.87% | 534.76% | |
| 68Neutral | $2.68B | 14.16 | 9.51% | 1.88% | 1.48% | 72.33% | |
| 62Neutral | $8.31B | 40.39 | 7.39% | 0.94% | 39.62% | -14.83% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 60Neutral | $2.60B | 26.34 | 7.02% | 1.39% | 8.68% | ― | |
| 56Neutral | $3.42B | 65.08 | 2.77% | 2.25% | -1.39% | ― |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:96S | Stepan Company | 61.50 | 26.00 | 73.22% | |
| ASH | Ashland Global Holdings, Inc. | 74.19 | 24.83 | 50.31% | |
| FUL | H.B. Fuller Company | 51.56 | -5.22 | -9.19% | |
| IOSP | Innospec | 99.55 | 26.43 | 36.15% | |
| KWR | Quaker Chemical | 148.05 | 15.21 | 11.45% | |
| ESI | Element Solutions | 34.14 | 7.39 | 27.61% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.